Amyotrophic lateral sclerosis epidemiology and demographics: Difference between revisions
(Created page with "__NOTOC__ {{Amyotrophic lateral sclerosis}} {{CMG}} ==Overview== ==Epidemiology and Demographics== *ALS is one of the most common neuromuscular diseases worldwide, and peopl...") |
Tooba Kashif (talk | contribs) |
||
| (15 intermediate revisions by 4 users not shown) | |||
| Line 2: | Line 2: | ||
{{Amyotrophic lateral sclerosis}} | {{Amyotrophic lateral sclerosis}} | ||
{{CMG}} | {{CMG}}{{AE}}{{MMJ}} | ||
==Overview== | ==Overview== | ||
The incidence and prevalence of ALS are rising globally. More resources should be dedicated to the advancement of care and research of ALS. | |||
*ALS is | |||
=Epidemiology and Demographics= | |||
===Incidence=== | |||
*The incidence of ALS is around 0.6-3.8 per 100000 person-years. | |||
===Prevalance=== | |||
The prevalence of ALS is between 4.1-8.4 per 100000 person-years. | |||
===Age Onset=== | |||
The median age of onset of ALS is between 51-66 years. | |||
===Gender=== | |||
The male population is more commonly affected by ALS than females. | |||
<ref name="pmid31361627">{{cite journal| author=Longinetti E, Fang F| title=Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. | journal=Curr Opin Neurol | year= 2019 | volume= 32 | issue= 5 | pages= 771-776 | pmid=31361627 | doi=10.1097/WCO.0000000000000730 | pmc=6735526 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31361627 }} </ref> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Motor neuron disease]] | |||
[[Category:Neurology]] | |||
[[Category:Disease]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 21:04, 21 July 2021
|
Amyotrophic lateral sclerosis Microchapters |
|
Differentiating Amyotrophic lateral sclerosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Amyotrophic lateral sclerosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Amyotrophic lateral sclerosis epidemiology and demographics |
|
FDA on Amyotrophic lateral sclerosis epidemiology and demographics |
|
CDC on Amyotrophic lateral sclerosis epidemiology and demographics |
|
Amyotrophic lateral sclerosis epidemiology and demographics in the news |
|
Blogs on Amyotrophic lateral sclerosis epidemiology and demographics |
|
Risk calculators and risk factors for Amyotrophic lateral sclerosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
The incidence and prevalence of ALS are rising globally. More resources should be dedicated to the advancement of care and research of ALS.
Epidemiology and Demographics
Incidence
- The incidence of ALS is around 0.6-3.8 per 100000 person-years.
Prevalance
The prevalence of ALS is between 4.1-8.4 per 100000 person-years.
Age Onset
The median age of onset of ALS is between 51-66 years.
Gender
The male population is more commonly affected by ALS than females.
References
- ↑ Longinetti E, Fang F (2019). "Epidemiology of amyotrophic lateral sclerosis: an update of recent literature". Curr Opin Neurol. 32 (5): 771–776. doi:10.1097/WCO.0000000000000730. PMC 6735526 Check
|pmc=value (help). PMID 31361627.